Aviva's £1 Billion Cancer Research Centre Ambition

Deal News | May 01, 2025 | Aviva PLC

Aviva Capital Partners, the investment arm of Aviva PLC, has announced a collaborative initiative with mixed-use developer Socius to create a new £1 billion development in Sutton, London. This ambitious project aims to establish the world's leading centre for cancer research and treatment. The proposed centre is expected to be a significant innovation in the field of healthcare infrastructure in the UK, leveraging both Aviva's investment capabilities and Socius’s development expertise. With plans to integrate cutting-edge research facilities and treatment hubs, the development promises to bolster the UK's leadership in medical research and offer substantial contributions to global cancer studies.

Sectors

Healthcare Infrastructure
Real Estate Development

Geography

United Kingdom – The development is planned to take place in Sutton, London, a key area in the UK.
London – Specific mention of Sutton, London, as the location of the proposed project emphasizes the regional focus of the investment.

Industry

Healthcare Infrastructure – The article discusses a significant investment into developing a centre for cancer research and treatment, which falls under the healthcare infrastructure sector.
Real Estate Development – The involvement of Socius, a mixed-use developer, highlights the role of real estate development in the creation of this new facility.

Financials

£1 billion – The total investment announced for the development of the cancer research and treatment centre.

Participants

Name	Role	Type	Description
Aviva PLC	Parent Company	Company	Aviva PLC is the parent company of Aviva Capital Partners and is involved in various financial services.
Aviva Capital Partners	Investor	Company	Aviva's in-house investment unit focusing on infrastructure and real estate projects.
Socius	Developer	Company	A mixed-use developer partnering with Aviva Capital Partners on this project.